glp-1 news insurers Harvard Pilgrim, Tufts Health Plan CEO talks weight-loss drug coverage Disappointing GLP-1 Results in Alzheimer's

doi: 10.1038/s44259-023-00007-2 226 LeiJ.et al

Adv Neurobiol 13:5998 McKenna MC, Rae CD (2015) A new role for alpha-ketoglutarate dehydrogenase complex: regulating metabolism through post-translational modification of other enzymes

The medications, known as GLP-1 receptor agonists, mimic this hormone to regulate several key bodily functions

Extended schedules often describe a break of around four weeks or longer

The SELECT trial results and subsequent research have generated excitement within the medical community, with experts suggesting a paradigm shift in how we approach CVD management for individuals with obesity